Infection complicates a substantial proportion of diabetic foot ulcers and is a leading precipitant of hospitalization and lower-limb amputation. Because ulcers are colonized by bacteria whether or not they are infected, clinicians must distinguish true infection, defined by inflammatory signs, from colonization. They must then choose antibiotics that are effective but not excessive. This article reviews recent evidence on the microbiology of diabetic foot infection, how samples should be obtained, and how long soft tissue infection should be treated.
Which Organisms Cause Diabetic Foot Infection?
A 2021 meta-analysis by Macdonald and colleagues in BMC Infectious Diseases pooled 112 studies, including 16,159 patients and 22,198 microbial isolates. About 59% of infections were polymicrobial, with roughly 1.5 isolates per positive culture. Staphylococcus aureus was the most common single organism, found in about 21–23% of cases, and methicillin-resistant S. aureus (MRSA) accounted for approximately 18% of S. aureus isolates. Pseudomonas species appeared in about 10–11% of infections, while Escherichia coli, Proteus, and Klebsiella species each contributed smaller shares.
Two further findings are clinically relevant. Anaerobes were reported infrequently: only Bacteroides (about 2%) and Peptostreptococcus (about 1.4%) exceeded 1% prevalence, although detection depends on culture technique. Geography also matters. Gram-positive organisms made up about 62% of isolates in high-income countries but only about 40% in upper- and lower-middle-income countries, where Gram-negative bacteria predominated. Local resistance patterns should therefore shape empirical therapy.
Diagnosis and Specimen Collection
The 2023 IWGDF/IDSA guideline update (Senneville et al., Diabetes/Metabolism Research and Reviews, 2024) drew on 149 studies and grades infection severity using a standardized classification. It emphasizes that infection is a clinical diagnosis based on local or systemic signs of inflammation, not on a positive culture alone. Clinically uninfected wounds should not be treated with antibiotics.
When infection is present, culture is intended to guide definitive therapy. The guideline favours properly obtained tissue specimens, ideally after debridement, over superficial swabs, which tend to capture surface colonizers. It also recommends conventional culture over molecular methods as the first-line approach to pathogen identification. Early recognition and, where needed, prompt surgical drainage of abscesses or devitalized tissue remain central to outcomes, with antibiotics as an adjunct.
Topical and Adjunctive Measures
The same guideline does not recommend topical antiseptics, silver preparations, honey, bacteriophage therapy, negative pressure wound therapy, or adjunctive granulocyte colony-stimulating factor for the specific purpose of treating infection. Topical antimicrobials are not suggested for mild infection. The evidence for these measures was judged insufficient to show benefit on infection outcomes, which reinforces systemic therapy and source control as the foundation of treatment.
How Long Should Antibiotics Be Given?
Duration has long been guided more by habit than by trial data, and over-treatment contributes to adverse events and antimicrobial resistance. Pham and colleagues published a randomized, non-inferiority pilot trial in Annals of Surgery (2022) that compared 10 days with 20 days of post-debridement antibiotics in 66 episodes of moderate to severe soft tissue diabetic foot infection without osteomyelitis. Most treatment was oral after a median of one day of parenteral therapy. Clinical remission at two months was 77% with 10 days and 71% with 20 days (p = 0.57), and adverse events were similar between groups (14 of 35 versus 11 of 31).
The trial was small, its confidence intervals were wide, and the authors described it as a pilot with a larger confirmatory study planned. It nonetheless supports the broader principle, reflected in current guidance, that soft tissue infection generally warrants a relatively short course, typically one to two weeks. The course can be reassessed and extended when response is slow or when perfusion is poor. Bone involvement is managed differently: for osteomyelitis, the guideline suggests up to about three weeks of antibiotics after minor amputation with a positive bone margin culture, and about six weeks when no bone is resected.
Clinical Summary
Diabetic foot infection is usually polymicrobial, with S. aureus the leading single pathogen and substantial regional variation in Gram-negative and resistant organisms. Treatment should target clinically infected wounds only, be guided by deep tissue cultures where possible, and be paired with timely debridement or drainage. Evidence, although limited, suggests that shorter post-debridement antibiotic courses can achieve outcomes comparable to longer ones in soft tissue infection, and larger trials will refine duration recommendations.
References
- Macdonald KE, Boeckh S, Stacey HJ, Jones JD. The microbiology of diabetic foot infections: a meta-analysis. BMC Infectious Diseases. 2021;21:770.
- Senneville É, Albalawi Z, van Asten SA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3687.
- Pham TT, Gariani K, Richard JC, Kressmann B, Jornayvaz F, Philippe J, Lipsky BA, Uçkay I. Moderate to severe soft tissue diabetic foot infections: a randomized, controlled, pilot trial of post-debridement antibiotic treatment for 10 versus 20 days. Annals of Surgery. 2022;276(2):233-238.
Comments
